Synaptogenesis: A Key Process in Alzheimer's Disease (AD)

Understanding how synaptogenesis is affected in AD provides essential insights into disease progression and opens avenues for therapeutic intervention.
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Synaptogenesis, the formation of new synaptic connections between neurons, is vital for brain plasticity, learning, and memory. In Alzheimer’s disease (AD), synaptogenesis is profoundly disrupted, and its impairment is a critical driver of the cognitive deficits associated with the disease. Understanding how synaptogenesis is affected in AD provides essential insights into disease progression and opens avenues for therapeutic intervention.

Why Synaptogenesis Matters in AD

  1. Cognitive Function is Synapse-Dependent:

    • The number and strength of synapses in the brain correlate directly with cognitive abilities such as memory, reasoning, and learning.
    • Synaptic loss is the best correlate of cognitive decline in AD, even more than amyloid plaques or tau tangles.
  2. Synaptic Plasticity Supports Memory:

    • Synaptogenesis enables the brain to adapt by forming new connections in response to learning and experience.
    • In AD, impaired synaptogenesis means the brain cannot compensate for lost connections, leading to progressive memory and cognitive deficits.
  3. Early Synaptic Dysfunction in AD:

    • Synaptic changes occur in the early stages of AD, before significant neuronal loss or the appearance of clinical symptoms.
    • These early changes make synaptogenesis a key target for early detection and intervention.

How Synaptogenesis is Impaired in AD

  1. Amyloid-β Toxicity:

    • Amyloid-β (Aβ) oligomers accumulate at synapses, disrupting neurotransmitter receptor clustering and interfering with synaptic signaling.
    • Aβ also activates the complement system, marking synapses for excessive pruning by microglia.
  2. Tau Pathology:

    • Hyperphosphorylated tau destabilizes microtubules, impairing the transport of synaptic proteins and vesicles.
    • Tau aggregation in dendrites directly disrupts postsynaptic signaling and dendritic spine stability.
  3. Neuroinflammation:

    • Activated microglia and astrocytes release pro-inflammatory cytokines, damaging synapses and disrupting their repair mechanisms.
    • Chronic inflammation exacerbates synaptic loss and hinders recovery.
  4. Loss of Neurotrophic Factors:

    • Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF), essential for synaptic growth and maintenance, are reduced in AD.
    • Insufficient neurotrophic support leads to weakened synaptic connectivity.
  5. Mitochondrial Dysfunction:

    • Synaptogenesis is energy-intensive, requiring ATP for vesicle transport, receptor clustering, and cytoskeletal remodeling.
    • Mitochondrial dysfunction in AD reduces ATP production and increases oxidative stress, impairing synaptic repair and growth.

Key Players in Synaptogenesis in AD

  1. Neurons:

    • Neurons form the physical structure of synapses. In AD, their ability to create and stabilize new synaptic connections is compromised by Aβ and tau pathology.
  2. Astrocytes:

    • Astrocytes support synaptogenesis by secreting synaptogenic factors like thrombospondins and cholesterol. In AD, reactive astrocytes lose their ability to promote synapse formation and instead contribute to inflammation.
  3. Microglia:

    • Microglia regulate synaptic pruning to refine connections. In AD, overactivation of microglia leads to excessive synaptic elimination through complement-mediated mechanisms.

Markers of Synaptogenesis in AD

Tracking synaptogenesis in AD involves monitoring specific markers related to synaptic structure and function:

  • Presynaptic Markers:
    • Synaptophysin (SYP): Indicates presynaptic vesicle integrity.
    • Synapsin-1: Regulates synaptic vesicle trafficking.
  • Postsynaptic Markers:
    • PSD-95: Scaffolding protein critical for receptor clustering and postsynaptic density.
    • Gephyrin: Key for inhibitory synapse stability.
  • Complement Proteins:
    • C1q and C3: Indicate complement-mediated synapse pruning.

Therapeutic Implications

  1. Targeting Amyloid and Tau:

    • Anti-Aβ therapies (e.g., lecanemab) aim to reduce amyloid burden, potentially preventing synaptic damage.
    • Tau-targeting therapies could stabilize microtubules and restore axonal transport.
  2. Enhancing Neurotrophic Support:

    • BDNF mimetics or modulators of TrkB receptors could promote synaptogenesis and counteract synaptic loss.
  3. Modulating Microglia and Inflammation:

    • Complement inhibitors or anti-inflammatory drugs could prevent excessive synaptic pruning and promote synaptic recovery.
  4. Lifestyle Interventions:

    • Physical exercise, enriched environments, and cognitive training enhance activity-dependent synaptogenesis through neurotrophic factor upregulation.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Biomedical Engineering and Bioengineering
Technology and Engineering > Biological and Physical Engineering > Biomedical Engineering and Bioengineering
Biomedical Research
Life Sciences > Health Sciences > Biomedical Research
Neuroscience
Life Sciences > Biological Sciences > Neuroscience
Alzheimer's disease
Life Sciences > Health Sciences > Clinical Medicine > Neurology > Neurological Disorders > Neurodegenerative diseases > Alzheimer's disease